Sign In
Buy CRSP
$53.99
-0.370 (-0.681%)
At Close: Jun 23, 2026
The Best Stocks to Invest $1,000 in Right Now
08:45am, Monday, 22'nd Jun 2026
Exploring some of the top bargains in a multi-trillion-dollar industry.
Why CRISPR Therapeutics Stock Has Been on a Roller-Coaster Ride This Year
09:00am, Thursday, 18'th Jun 2026
The opportunity is enormous, but uncertainty remains.
CRISPR Therapeutics AG (CRSP) Ascends While Market Falls: Some Facts to Note
06:50pm, Wednesday, 17'th Jun 2026
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $53.09, indicating a +2.06% shift from the previous trading day.
The Best Biotech Stocks to Buy in 2026
04:00pm, Wednesday, 17'th Jun 2026
They have at least one thing in common: An exciting pipeline.
The Healthcare M&A Wave
12:30pm, Wednesday, 17'th Jun 2026
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
Here's How I'd Invest $10,000 Right Now
12:30pm, Wednesday, 17'th Jun 2026
My strategy involves focusing on dividends, growth, and also taking on some calculated risk.
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 16'th Jun 2026
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts
06:51pm, Thursday, 11'th Jun 2026
In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $50.27, denoting a +1.68% move from the preceding trading day.
VO: Mid Caps Now Look Attractive, But Vanguard's $103 Billion ETF Misses The Mark
04:14pm, Thursday, 11'th Jun 2026
VO is a low-cost ETF offered by Vanguard, providing broad exposure to U.S. mid-cap stocks as defined by CRSP. However, CRSP Indexes allow overlap with the small/large-cap segments, impacting efficienc
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
07:01pm, Wednesday, 10'th Jun 2026
CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $49.47, signifying a -3.9% move from its prior day's close.
CRISPR Therapeutics AG (CRSP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
05:02pm, Tuesday, 09'th Jun 2026
CRISPR Therapeutics AG (CRSP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
The biotech has won approval for one of the few gene-editing therapies on the market. Several more therapies based on the same science are in the works.
CRISPR Therapeutics AG (CRSP) Presents at 46th Annual William Blair Growth Stock Conference Transcript
07:32pm, Thursday, 04'th Jun 2026
CRISPR Therapeutics AG (CRSP) Presents at 46th Annual William Blair Growth Stock Conference Transcript
CRISPR Therapeutics AG (CRSP) Presents at Jefferies Global Healthcare Conference 2026 Transcript
09:32pm, Wednesday, 03'rd Jun 2026
CRISPR Therapeutics AG (CRSP) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Why Is CRISPR Therapeutics (CRSP) Down 0.7% Since Last Earnings Report?
12:30pm, Wednesday, 03'rd Jun 2026
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock?
